Sabrina Rebecca Prommersberger

8PUBLICATIONS
55CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyInnate immunityMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 10, 2025
Boosting CAR T-cell efficacy by blocking proteasomal degradation of membrane antigens.

Leonie Rieger, Kilian Irlinger, Franziska Füchsl

|Jan 08, 2025
Current Non-Viral-Based Strategies to Manufacture CAR-T Cells.

Leon Gehrke, Vasco Dos Reis Gonçalves, Dominik Andrae

|Nov 27, 2024
Cellular Therapies for Multiple Myeloma: Engineering Hope.

Sarah Vera-Cruz, Maria Jornet Culubret, Verena Konetzki

|Nov 24, 2023
BCMA CAR-T cells in multiple myeloma-ready for take-off?

Lukas Scheller, Erius Tebuka, Peter Fabian Rambau

|Sep 28, 2022
CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models.

Michelle Seif, Tamara Katharina Kakoschke, Frank Ebel

|Jan 20, 2022
A Clinical Case of COVID-19-Associated Pulmonary Aspergillosis (CAPA), Illustrating the Challenges in Diagnosis (Despite Overwhelming Mycological Evidence).

P Lewis White, Jan Springer, Matt P Wise

Pageof 2

Frequent Collaborators

7 joint publications

Michael Hudecek

6 joint publications

Hermann Einsele

2 joint publications

Sophia Danhof

2 joint publications

Verena Konetzki